Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Woitalla

Showing results (31-40 of 70) with videos related to

Pageof 7
Sort By:
Fortschritte Der Neurologie-Psychiatrie|June 27, 2020
[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease]Dirk Woitalla, Rejko Krüger, Stefan Lorenzl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 31, 2022
GBA-associated PD: chances and obstacles for targeted treatment strategiesGünter Höglinger, Claudia Schulte, Wolfgang H Jost, et al.
Journal of Negative Results in Biomedicine|December 16, 2005
Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populationsAnna Melissa Schlitter, Martin Kurz, Jan P Larsen, et al.
Biochimica Et Biophysica Acta|March 11, 2014
Autoimmune profiling with protein microarrays in clinical applicationsLaura Abel, Simone Kutschki, Michael Turewicz, et al.
Journal of Neurology|May 2, 2006
Levodopa availability improves with progression of Parkinson's diseaseDirk Woitalla, Oliver Goetze, Jeong I Kim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 1, 2008
A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson's disease patientsClaudia Wahl, Sabine Kautzmann, Guido Krebiehl, et al.
Neurological Research|October 13, 2018
Landscape of pain in Parkinson's disease: impact of gender differencesMaria Angela Samis Zella, Caroline May, Thomas Müller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 12, 2025
Parkinson's Disease Multidisciplinary Complex Therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson's disease in Germany and the needs of future developmentRaphael Scherbaum, Matthias Höllerhage, Stephan Klebe, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 18, 2015
Laboratory assessments in the course of Parkinson's disease: a clinician's perspectiveThomas Müller, Horst Baas, Jan Kassubek, et al.
Journal of Neurology|June 18, 2010
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosisHela-Felicitas Petereit, Dirk Reske, Hayrettin Tumani, et al.
Pageof 7

Showing results (31-40 of 70) with videos related to

Sort By:
Pageof 7
Fortschritte Der Neurologie-Psychiatrie|June 27, 2020
[The role of inhibitors of COMT and MAO-B in the therapy of Parkinson's disease]Dirk Woitalla, Rejko Krüger, Stefan Lorenzl, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 31, 2022
GBA-associated PD: chances and obstacles for targeted treatment strategiesGünter Höglinger, Claudia Schulte, Wolfgang H Jost, et al.
Journal of Negative Results in Biomedicine|December 16, 2005
Exclusion of PINK1 as candidate gene for the late-onset form of Parkinson's disease in two European populationsAnna Melissa Schlitter, Martin Kurz, Jan P Larsen, et al.
Biochimica Et Biophysica Acta|March 11, 2014
Autoimmune profiling with protein microarrays in clinical applicationsLaura Abel, Simone Kutschki, Michael Turewicz, et al.
Journal of Neurology|May 2, 2006
Levodopa availability improves with progression of Parkinson's diseaseDirk Woitalla, Oliver Goetze, Jeong I Kim, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|May 1, 2008
A comprehensive genetic study of the proteasomal subunit S6 ATPase in German Parkinson's disease patientsClaudia Wahl, Sabine Kautzmann, Guido Krebiehl, et al.
Neurological Research|October 13, 2018
Landscape of pain in Parkinson's disease: impact of gender differencesMaria Angela Samis Zella, Caroline May, Thomas Müller, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|June 12, 2025
Parkinson's Disease Multidisciplinary Complex Therapy (PD-MCT): appreciation of its current function for the treatment of people with Parkinson's disease in Germany and the needs of future developmentRaphael Scherbaum, Matthias Höllerhage, Stephan Klebe, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|November 18, 2015
Laboratory assessments in the course of Parkinson's disease: a clinician's perspectiveThomas Müller, Horst Baas, Jan Kassubek, et al.
Journal of Neurology|June 18, 2010
Soluble CSF interleukin 2 receptor as indicator of neurosarcoidosisHela-Felicitas Petereit, Dirk Reske, Hayrettin Tumani, et al.
Pageof 7